Immix Biopharma
IMMX
IMMX
67 hedge funds and large institutions have $127M invested in Immix Biopharma in 2025 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
63.02% more ownership
Funds ownership: 9.59% → 72.62% (+63%)
48% less call options, than puts
Call options by funds: $225K | Put options by funds: $436K
Holders
67
Holding in Top 10
–
Calls
$225K
Puts
$436K
Top Buyers
| 1 | +$16.1M | |
| 2 | +$12.3M | |
| 3 | +$10.5M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$7.92M |
| 5 |
Millennium Management
New York
|
+$6.83M |
Top Sellers
| 1 | -$195K | |
| 2 | -$59.5K | |
| 3 | -$51.3K | |
| 4 |
SS
SBI Securities
Tokyo,
Japan
|
-$30.9K |
| 5 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$24.9K |
